Concorde Asset Management’s Alignment Healthcare ALHC Stock Holding History

Concorde Asset Management’s Portfolio ALHC Stock Details ALHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$900K	Sell	37,800 -300	-0.8%	-$5.76K	0.52%	37
2026 Q1	$671K	Hold	38,100	–	–	0.33%	65
2025 Q4	$752K	Hold	38,100	–	–	0.3%	72
2025 Q3	$621K	Buy	+38,100	New	+$565K	0.26%	84
2025 Q1	$603K	Hold	32,520	–	–	0.32%	46
2024 Q4	$366K	Hold	32,520	–	–	0.19%	89
2024 Q3	$384K	Sell	32,520 -23,500	-42%	-$222K	0.22%	85
2024 Q2	$438K	Sell	56,020 -600	-1%	-$3.92K	0.27%	68
2024 Q1	$281K	Buy	56,620 +33,640	+146%	+$215K	0.19%	103
2023 Q4	$198K	Sell	22,980 -10,800	-32%	-$79K	0.13%	148
2023 Q3	$234K	Hold	33,780	–	–	0.21%	120
2023 Q2	$194K	Hold	33,780	–	–	0.18%	119
2023 Q1	$215K	Sell	33,780 -4,000	-11%	-$38.1K	0.25%	71
2022 Q4	$444K	Sell	37,780 -10,600	-22%	-$129K	0.4%	62
2022 Q3	$573K	Sell	48,380 -14,000	-22%	-$204K	0.64%	49
2022 Q2	$712K	Sell	62,380 -3,200	-5%	-$33.8K	1.07%	26
2022 Q1	$736K	Sell	65,580 -3,000	-4%	-$27K	0.49%	64
2021 Q4	$964K	Buy	+68,580	New	+$1.2M	0.58%	62

Other funds holding ALHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Concorde Asset Management's ALHC Position: Q2 2026 in Review

Concorde Asset Management reduced its Alignment Healthcare (ALHC) stake by 0.79% in Q2 2026, selling an estimated $5.76K and leaving 37,800 shares worth $900K. The position accounts for 0.52% of the portfolio, ranked #37.

Concorde Asset Management first reported a position in ALHC in Q4 2021 and has held it in 18 quarters since. The position peaked at $964K in Q4 2021. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

Concorde Asset Management held 37,800 shares of Alignment Healthcare worth $900K as of Q2 2026.
Concorde Asset Management sold 300 Alignment Healthcare shares in Q2 2026, an estimated $5.76K.
Alignment Healthcare made up 0.52% of Concorde Asset Management's portfolio in Q2 2026, its #37 holding.
Concorde Asset Management first reported a position in Alignment Healthcare in Q4 2021 and has held it in 18 quarters since.
Concorde Asset Management's Alignment Healthcare position peaked at $964K in Q4 2021.
324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Concorde Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.